Related references
Note: Only part of the references are listed.Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues
Urszula Kozlowska et al.
WORLD JOURNAL OF STEM CELLS (2019)
Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies
Aleksandra Klimczak et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy
Ariel Bier et al.
BIOMATERIALS (2018)
Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy
Samara Camacari de Carvalho et al.
CYTOKINE (2018)
Human Umbilical Cord Perivascular Cells and Human Bone Marrow Mesenchymal Stromal Cells Transplanted Intramuscularly Respond to a Distant Source of Inflammation
Shiva Hamidian Jahromi et al.
STEM CELLS AND DEVELOPMENT (2018)
Immunobiology of Inherited Muscular Dystrophies
James G. Tidball et al.
COMPREHENSIVE PHYSIOLOGY (2018)
Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy - Phase I-II
Alper Dai et al.
DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE (2018)
Cell Therapy in Myology: Dynamics of Muscle Precursor Cell Death after Intramuscular Administration in Non-human Primates
Daniel Skuk et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Epigenetic Reprogramming of Muscle Progenitors: Inspiration for Clinical Therapies
Silvia Consalvi et al.
STEM CELLS INTERNATIONAL (2016)
Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice
Margaret E. Benny Klimek et al.
PLOS ONE (2016)
Inflammatory predisposition predicts disease phenotypes in muscular dystrophy
Yuko Nitahara-Kasahara et al.
INFLAMMATION AND REGENERATION (2016)
Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status
Oriana del Rocio Cruz-Guzman et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications
E. M. Moran et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Macrophage Plasticity in Skeletal Muscle Repair
Elena Rigamonti et al.
BIOMED RESEARCH INTERNATIONAL (2014)
From Innate to Adaptive Immune Response in Muscular Dystrophies and Skeletal Muscle Regeneration: The Role of Lymphocytes
Luca Madaro et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
Boel De Paepe et al.
MEDIATORS OF INFLAMMATION (2013)
Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy
L. De Pasquale et al.
NEUROLOGY (2012)
Muscle histology vs MRI in Duchenne muscular dystrophy
M. Kinali et al.
NEUROLOGY (2011)
Stem cells to treat muscular dystrophies - Where are we?
Jinhong Meng et al.
NEUROMUSCULAR DISORDERS (2011)
Mesenchymal stem cells as anti-inflammatories: Implications for treatment of Duchenne muscular dystrophy
Thomas E. Ichim et al.
CELLULAR IMMUNOLOGY (2010)
Dystrophin Gene Mutation Location and the Risk of Cognitive Impairment in Duchenne Muscular Dystrophy
Peter J. Taylor et al.
PLOS ONE (2010)
Cell Based Therapy for Duchenne Muscular Dystrophy
Andrea Farini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials
Giulio Cossu et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Stem cell based therapies to treat muscular dystrophy
F. D. Price et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
First test of a high-density injection protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up
Daniel Skuk et al.
NEUROMUSCULAR DISORDERS (2007)
Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells
Daniel Skuk et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells
D Skuk et al.
MOLECULAR THERAPY (2004)
Dystrophin and mutations: one gene, several proteins, multiple phenotypes
F Muntoni et al.
LANCET NEUROLOGY (2003)
Cyclosporine blocks muscle differentiation by inducing oxidative stress and by inhibiting the peptidylprolyl-cis-trans-isomerase activity of cyclophilin A:: cyclophilin A protects myoblasts from cyclosporine-induced cytotoxicity
F Hong et al.
FASEB JOURNAL (2002)
Share Paper
